STOCK TITAN

Cardiff Lexington (CDIX) CFO receives 62,500-share restricted stock award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cardiff Lexington Corp Chief Financial Officer granted restricted stock. On January 13, 2026, CFO Matthew T. Shafer received a restricted stock award of 62,500 shares of Cardiff Lexington common stock under the company’s 2024 Equity Incentive Plan at a grant price of $0 per share. Of this award, 31,250 shares vested immediately on the grant date, while 15,625 shares are scheduled to vest on January 2, 2027 and another 15,625 shares on January 2, 2028, conditioned on his continuous service with the company. Following this equity grant, Shafer directly beneficially owned 74,168 shares of Cardiff Lexington common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shafer Matthew T

(Last) (First) (Middle)
3753 HOWARD HUGHES PARKWAY, SUITE 200

(Street)
LAS VEGAS NV 89169

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cardiff Lexington Corp [ CDIX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
01/13/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/13/2026 A(1) 62,500 A $0 74,168 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On January 13, 2026, the Reporting Person was granted a restricted stock award for 62,500 shares of Common Stock under the Issuer's 2024 Equity Incentive Plan, of which 31,250 shares vested on the date of grant and 15,625 shares shall vest on each of January 2, 2027 and January 2, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan).
/s/ Matthew T. Shafer 01/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cardiff Lexington (CDIX) report for its CFO?

Cardiff Lexington reported that Chief Financial Officer Matthew T. Shafer received a restricted stock award of 62,500 common shares on January 13, 2026 under the company’s 2024 Equity Incentive Plan.

How many Cardiff Lexington shares were granted to the CFO and at what price?

The CFO was granted 62,500 shares of common stock at a grant price of $0 per share, reflecting a stock-based compensation award rather than a market purchase.

What are the vesting terms of the CFO’s 62,500-share restricted stock award at Cardiff Lexington (CDIX)?

Of the 62,500-share award, 31,250 shares vested immediately on January 13, 2026. The remaining 15,625 shares are scheduled to vest on January 2, 2027 and another 15,625 shares on January 2, 2028, subject to the CFO’s continuous service.

Under what plan was the Cardiff Lexington CFO’s restricted stock granted?

The 62,500-share restricted stock award to the CFO was granted under Cardiff Lexington’s 2024 Equity Incentive Plan, as disclosed in the filing footnote.

How many Cardiff Lexington (CDIX) shares does the CFO own after this grant?

After the reported restricted stock grant and related vesting, CFO Matthew T. Shafer directly beneficially owned 74,168 shares of Cardiff Lexington common stock.

Are the remaining unvested Cardiff Lexington shares contingent on the CFO’s service?

Yes. The 15,625 shares scheduled to vest on January 2, 2027 and the 15,625 shares scheduled to vest on January 2, 2028 will vest only if the CFO maintains continuous service with the company under the terms of the 2024 Equity Incentive Plan.

Cardiff Lexingto

OTC:CDIX

CDIX Rankings

CDIX Latest News

CDIX Latest SEC Filings

CDIX Stock Data

29.52M
35.31M
10.72%
0.01%
Medical Care Facilities
Healthcare
Link
United States
Las Vegas